估计因COVID-19相关疫苗接种覆盖率下降而易感麻疹的美国儿童数量
研究基于2008-2017年NIS-Teen调查中有提供者验证接种记录的受访者,利用接种年龄估计接种概率并建模人群麻疹免疫与易感比例。当前估计9,145,026名儿童(13.1%)对麻疹易感;若按大流行期接种率且不补种,易感儿童将达15,165,221名(21.7%),补种可减少2-3%下降时则为9,454,436名(13.5%)。全国疫苗犹豫增加10%时,无论大流行期接种水平如何,易感儿童为14,925,481名(21.37%)。
要点
- 当前估计9,145,026名儿童(13.1%)对麻疹易感。
- 大流行期接种率下不补种,易感儿童达15,165,221名(21.7%)。
- 补种可减少2-3%下降时,易感儿童为9,454,436名(13.5%)。
核心结论
- 当前麻疹免疫水平仍低于群体免疫阈值。
- 若大流行时期儿童免疫接种的下降未得到纠正,人群对麻疹的免疫可能进一步下降。
研究设计与样本
- 研究纳入2008至2017年间NIS-Teen调查的受访者,且具有提供者验证的疫苗接种记录。
- 暴露因素为接种含麻疹疫苗(MCV)及所有剂次的接种年龄,利用接种年龄估计基于年龄的接种概率并建模人群MCV免疫与易感水平。
- 研究估计当前0-18岁儿童对麻疹易感的人数,并在疫苗接种下降情景中建模易感比例。
主要发现
- 当前估计9,145,026名儿童(13.1%)对麻疹易感。
- 在大流行水平疫苗接种率下,若不尝试补种,15,165,221名儿童(21.7%)将对麻疹易感;若补种使下降减少2-3%,则为9,454,436名儿童(13.5%)。
- 基于疫苗犹豫增加的模型也显示全国水平易感增加,全国疫苗犹豫增加10%导致14,925,481名儿童(21.37%)对麻疹易感,无论大流行疫苗接种水平如何。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Measles elimination hinges on vaccination coverage remaining above 95% to retain sufficient community protection. Recent declines in routine measles vaccinations due to the COVID-19 pandemic coupled with prior models indicating the country was close to the 92% herd immunity benchmark are a cause for concern. We evaluated population-level measles susceptibility in the US, including sensitivity analyses accounting for pandemic-related impacts on immunization. We estimated the number of children aged 0-18 currently susceptible to measles and modeled susceptibility proportions in decreased vaccination scenarios. Participants were respondents to the NIS-Teen survey between 2008 and 2017 that also had provider-verified vaccination documentation. The exposure of interest was vaccination with a measles-containing vaccine (MCV), and the age at which they were vaccinated for all doses given. Using age at vaccination, we estimated age-based probabilities of vaccination and modeled population levels of MCV immunization and immunity vs. susceptibility. Currently, 9,145,026 children (13.1%) are estimated to be susceptible to measles. With pandemic level vaccination rates, 15,165,221 children (21.7%) will be susceptible to measles if no attempt at catch-up is made, or 9,454,436 children (13.5%) if catch-up vaccinations mitigate the decline by 2-3%. Models based on increased vaccine hesitancy also show increased susceptibility at national levels, with a 10% increase in hesitancy nationally resulting in 14,925,481 children (21.37%) susceptible to measles, irrespective of pandemic vaccination levels. Current levels of measles immunity remain below herd immunity thresholds. If pandemic-era reductions in childhood immunization are not rectified, population-level immunity to measles is likely to decline further.
引用
- Gambrell A, Sundaram M, Bednarczyk RA, et al. Estimating the number of US children susceptible to measles resulting from COVID-19-related vaccination coverage declines. Vaccine. 2022. PMID: 35728989. doi:10.1016/j.vaccine.2022.06.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。